Medicover operates in the healthcare industry. The company is an international healthcare and diagnostics company and focuses on providing medical services and laboratory analyses. The company's services are aimed at individuals and companies that need fast and accessible care. Medicover was founded in 1994 and is headquartered in Stockholm, Sweden.
* Q2 broadly in line across most line items * '26e-'28e adj. EBITDA -0.7%/-0.4%/-0.4% on weaker Romania * FVR unchanged at SEK 190-270 on minor estimate revisions Broadly in line, Romania weighs Revenue grew 7.3% y-o-y to EUR 640m, with org. growth acceleratin...
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
* -1%/0% adj. EBITDA vs ABGSCe/Infront cons in Q2 * Cons estimates likely unchanged * Trading at 10.2x '26e EV/EBITDA Q2 results: In line with expectations Medicover reported a second quarter in line with cons. Q2 sales were EUR 640m (0% vs ABGSCe, 0...
* Q2'26 numbers due on 22 July at 07:45 CET * Minor estimate changes, margins unchanged * Fair value range kept at SEK 190-270 Q2'26 expectations For Q2, we expect Medicover to perform broadly in line with Q1'26. In Poland and Romania, government funding...
* Strong Q1 beat with 110bps margin expansion on adj. EBITDA * Adj. EBITDA up 1% for '26e-'28e on Q1 beat * FVR unchanged at SEK 190-270 on minor estimate revisions A solid start to '26 despite weather drag Q1 was 8%/6% above ABGSCe/Infront consensus...
* 8%/6% adj. EBITDA vs ABGSCe/Infront cons in Q1 * Cons estimates likely up 1-3% on adj. EBITDA '26e * Model proved itself despite the weather headwind we flagged Q1 results Medicover reported a strong start to '26 with sales in-line vs cons and a clear...
* Q1'26 numbers due on 29 April at 07:45 CET * Near-term caution, but the model should continue to prove itself * Fair value range down to SEK 190-270 (200-280) Q1'26 should be marked by cold weather We expect colder-than-usual temperatures and severe...
